Literature DB >> 21219186

Pathogenesis and host control of gammaherpesviruses: lessons from the mouse.

Erik Barton1, Pratyusha Mandal, Samuel H Speck.   

Abstract

Gammaherpesviruses are lymphotropic viruses that are associated with the development of lymphoproliferative diseases, lymphomas, as well as other nonlymphoid cancers. Most known gammaherpesviruses establish latency in B lymphocytes. Research on Epstein-Barr virus (EBV) and murine gammaherpesvirus 68 (MHV68/γHV68/MHV4) has revealed a complex relationship between virus latency and the stage of B cell differentiation. Available data support a model in which gammaherpesvirus infection drives B cell proliferation and differentiation. In general, the characterized gammaherpesviruses exhibit a very narrow host tropism, which has severely limited studies on the human gammaherpesviruses EBV and Kaposi's sarcoma-associated herpesvirus. As such, there has been significant interest in developing animal models in which the pathogenesis of gammaherpesviruses can be characterized. MHV68 represents a unique model to define the effects of chronic viral infection on the antiviral immune response.

Entities:  

Mesh:

Year:  2011        PMID: 21219186     DOI: 10.1146/annurev-immunol-072710-081639

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  133 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; William E Lawson; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-16       Impact factor: 5.464

3.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 4.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

5.  Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells.

Authors:  Alana M Bozeman; Sonia J Laurie; Divya Haridas; Maylene E Wagener; Mandy L Ford
Journal:  Transpl Immunol       Date:  2018-06-08       Impact factor: 1.708

Review 6.  Coinfections: Another Variable in the Herpesvirus Latency-Reactivation Dynamic.

Authors:  Tiffany A Reese
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

7.  Novel gammaherpesviruses in North American domestic cats, bobcats, and pumas: identification, prevalence, and risk factors.

Authors:  Ryan M Troyer; Julia A Beatty; Kathryn R Stutzman-Rodriguez; Scott Carver; Caitlin C Lozano; Justin S Lee; Michael R Lappin; Seth P D Riley; Laurel E K Serieys; Kenneth A Logan; Linda L Sweanor; Walter M Boyce; T Winston Vickers; Roy McBride; Kevin R Crooks; Jesse S Lewis; Mark W Cunningham; Joel Rovnak; Sandra L Quackenbush; Sue VandeWoude
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

Review 8.  Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Authors:  Silvia Montaner; Irina Kufareva; Ruben Abagyan; J Silvio Gutkind
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-10-22       Impact factor: 13.820

9.  Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.

Authors:  Vinita S Chauhan; Daniel A Nelson; Ian Marriott; Kenneth L Bost
Journal:  Autoimmunity       Date:  2013-04-16       Impact factor: 2.815

10.  Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.

Authors:  Andrew Getahun; Mia J Smith; Igor Kogut; Linda F van Dyk; John C Cambier
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.